Outcome of patients with meningomyelocele: the Ege University experience.
The medical records of 190 patients with meningomyelocele operated on between 1979 and 1993 were reviewed. In 65 patients, psychometric tests were performed. The Denver Developmental Screening Test and the Wechsler Intelligence Scale for Children, Revised (WISC-R) were used in children under and over 6 years old, respectively. There were 82 boys (43.2%) and 108 girls (56.8%). The lumbar region was the site of the meningomyelocele in 113 patients (59.5%). Patients with cervical and sacral meningomyelocele had a higher rate of almost normal motor function than those with meningomyelocele at other levels (P=0.000). Only 36 (21.7%) of 166 patients followed up by us did not have hydrocephalus. We also noted that the higher the location of the meningomyelocele, the greater the control of both sphincters (P=0.014). Fifty-four percent of the hydrocephalic patients had a normal development or IQ. Psychometric tests were normal in 76% of those without hydrocephalus. Twenty-four patients were lost to follow-up. The follow-up of the remaining 166 patients ranged from 1 month to 180 months (mean 60.2 months). Fifty-three patients (32%) died, central nervous system infection being the most common cause of death (44%). The management of children with meningomyelocele needs a team approach.
Mirzai
H
H
Division of Pediatric Neurosurgery, Ege University Faculty of Medicine, Izmir, Turkey.
Erşahin
Y
Y
Mutluer
S
S
Kayahan
A
A
D002557:Cerebrospinal Fluid Shunts; D004185:Disability Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006849:Hydrocephalus / Q000150:complications / Q000601:surgery; D007223:Infant; D007231:Infant, Newborn; D007360:Intelligence; D008297:Male; D008591:Meningomyelocele / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D009420:Nervous System / Q000503:physiopathology; D011183:Postoperative Complications; D011184:Postoperative Period; D011594:Psychometrics / Q000379:methods; D016019:Survival Analysis; D016896:Treatment Outcome